THE IMMUNOLOGICAL RELATIONSHIP OF THE CAPSULAR POLYSACCHARIDE OF TYPE XIV PNEUMOCOCCUS TO THE BLOOD GROUP A SPECIFIC SUBSTANCE
Open Access
- 1 September 1939
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 70 (3) , 239-247
- https://doi.org/10.1084/jem.70.3.239
Abstract
1. The agglutination of human erythrocytes and the precipitation of the blood group A substance by Type XIV antipneumococcus horse serum are properties of the specific anticarbohydrate immune bodies in the serum. 2. Absorption of Type XIV antipneumococcus horse serum with the homologous bacterial polysaccharide removes the agglutinins for human erythrocytes as well as the precipitins for the group A substance. 3. Absorption of Type XIV antipneumococcus horse serum with the group A substance markedly diminishes the ability of the serum to agglutinate erythrocytes of all groups. 4. Absorption of Type XIV antipneumococcus horse serum with human erythrocytes causes a marked diminution in the precipitation with group A substance. 5. The chemical and immunological relationship between the specific substances of blood group A and the Type XIV Pneumococcus is discussed.This publication has 8 references indexed in Scilit:
- THE ISOLATION OF THE BLOOD GROUP A SPECIFIC SUBSTANCE FROM COMMERCIAL PEPTONEThe Journal of Experimental Medicine, 1938
- Agglutinins for Human Erythrocytes in Type XIV Anti-Pneumococcic Horse SerumsScience, 1938
- CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINSThe Journal of Experimental Medicine, 1937
- A QUANTITATIVE STUDY OF THE CROSS REACTION OF TYPES III AND VIII PNEUMOCOCCI IN HORSE AND RABBIT ANTISERAThe Journal of Experimental Medicine, 1937
- ON GROUP SPECIFIC A SUBSTANCESThe Journal of Experimental Medicine, 1936
- ON THE GROUP SPECIFIC A SUBSTANCE IN HORSE SALIVA. IIThe Journal of Experimental Medicine, 1936
- STUDIES ON THE PRECIPITIN REACTIONThe Journal of Experimental Medicine, 1933
- ON THE PRESENCE IN ANTIPNEUMOCOCCUS SERUM OF TYPE-SPECIFIC PROTECTIVE ANTIBODY NOT NEUTRALIZED BY HOMOLOGOUS SPECIFIC SOLUBLE SUBSTANCEThe Journal of Experimental Medicine, 1931